Zetagen Therapeutics Secures 9.79 Million Usd Series B Funding Raise For Advancement Of Zetamet™ And Zetamast™ For Treatment Of Metastatic Bone And Soft Tissue Lesions
Round Type
Series B
SyracuseBiotechnologyHealthcareHealth CareInvestors
Description
Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company focused on driving breakthrough innovation in the treatment of metastatic cancers to bone and soft tissue organs as well as osteologic interventions, today announced the close of $9.79 million USD Series B funding round.
Quick answer
Zetagen Therapeutics raised an undisclosed amount in a Series B round, dated August 11, 2023. Investors: Consolidated Capital Investments, Llc and New York Ventures. Zetagen Therapeutics is based in Syracuse, New York, United States.
- How much did Zetagen Therapeutics raise?
- Zetagen Therapeutics raised an undisclosed amount in a Series B round on August 11, 2023.
- Who invested in Zetagen Therapeutics?
- Consolidated Capital Investments, Llc and New York Ventures are named as investors in this round.
- What does Zetagen Therapeutics do?
- Zetagen is a private, clinical-stage biopharmaceutical company founded in 2015, focused on pioneering treatments for metastatic bone cancers and osteologic interventions.
- Where is Zetagen Therapeutics based and how big is it?
- Zetagen Therapeutics is based in Syracuse, New York, United States.
- Who are the decision-makers at Zetagen Therapeutics?
- Fundz holds 3 contacts at Zetagen Therapeutics, including the Chief Scientific Officer and Co-founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Zetagen Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Avalyn raised $189M on September 22, 2023.
- Streamex Corp. raised $1.2M (Seed) on September 21, 2023.
- BrainScope raised an undisclosed amount on September 19, 2023.
- ReCode Therapeutics raised an undisclosed amount (Series B) on September 19, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Streamex Corp. raised $794K (Seed) on September 12, 2023.
Who to call at Zetagen Therapeutics, and when
A new round usually means Zetagen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Zetagen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zetagen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zetagen Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zetagen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansZetagen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.